Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

As part of a $93 million grant package, the Cancer Prevention and Research Institute of Texas, known for funding ...

Parker Institute showcases breakthroughs in immunotherapy at ASCO 2025 as CEO Dr. Karen Knudsen receives prestigious honor.

A variant in the IL-7 gene may predict which patients with kidney cancer are more likely to experience side effects from immunotherapy.

An colon cancer study highlighted the importance of the National Cancer Institute, while cancer doctors got a look at a ...

Equity Insider News Commentary – With early onset cancer rates on the rise and funding being cut to NIH, the future for ...

The BREAKWATER study enrolled patients with newly diagnosed colon cancer that harbors a mutation called BRAF 600E that makes ...

It's important to look carefully at the critiques prostate cancer screening guidelines and the role of PSA tests. There are ...

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – Baystreet.caNews Commentary – As traditional research institutions ...

At this year’s AACR 2025 (Chicago, IL, USA; 25–30 April), the annual meeting of the American Association for Cancer Research, we picked out our favourite posters from the ... with worse patient ...

A Queensland mother is procuring her legacy through a series of "healing" artworks that capture her most precious beachside ...